A mouse monoclonal antibody, H3a, directed against the newly described epidermolysis bullosa acquisita (EBA) antigen was obtained using hybridoma techniques. The distribution of the monoclonal antibody is identical to that of the polyclonal serum antibody of patients with EBA. By immunofluorescence, a linear band is seen at the dermal-epidermal junction and, by immunoelectron microscopy, immune reaction products are present in the lamina densa and sublamina densa regions. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western immunoblot analysis shows that the monoclonal antibody recognizes 290 and 145 kilodalton proteins present in the immunizing junctional extract, identical with the newly discovered EBA antigen. This monoclonal antibody should be useful in the further isolation and characterization of the EBA antigen

Briggaman, Robert

Gammon, W. Ray

O&apos

Paller, Amy

Queen, Laurinda

Woodley, David

English

Carolina Digital Repository

0022-202X/85/ 8403-0215$02.00/ 0 THE JOURNAL OF INVESTIGATIVE DEHMATOLOGV, 84 :215 - 2 17, 1985 Copyright © 1985 by The Williams & Wilkins Co. Vol. 84, No. 3 Printed in U.S.A. A Mouse Monoclonal Antibody Against a Newly Discovered Basement Membrane Component, the Epidermolysis Bullosa Acquisita Antigen AMY 8. PALLER, M.D., LAURINDA L. QUEEN, M.D., DAVID T. WOODLEY, M.D., W. RAY GAMMON, M.D., EDWARD J. O'KEEFE, M.D., AND ROBERT A. BRIGGAMAN, M.D. Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolinn, U.S.A. A mouse monoclonal antibody, H3a, directed against the newly described epidermolysis bullosa acquisita (EBA) antigen was obtained using hybridoma tech-niques. The distribution of the monoclonal antibody is identical to that of the polyclonal serum antibody of patients with EBA. By immunofluorescence, a linear band is seen at the dermal-epidermal junction and, by immunoelectron microscopy, immune reaction products are present in the lamina densa and sublamina densa regions. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western immunoblot analy-sis shows that the monoclonal antibody recognizes 290 and 145 kilodalton proteins present in the immunizing junctional extract, identical with the newly discovered EBA antigen. This monoclonal antibody should be useful in the further isolation and characterization of the EBA antigen. Epidermolysis bullosa acquisita (EBA) is a subepidermal blistering disease characterized by tissue-bound antibodies and circulating IgG autoantibodies to a normal component of the cutaneous basement membrane zone (BMZ). lmmunoelectron microscopic studies have shown that this component is present in the lamina densa and sublamina densa regions of the BMZ [1-3]. In a recent study [4], BMZ proteins were extracted from normal human skin, separated by sodium dodecyl sulfate-poly-acrylamide gel electrophoresis (SDS-PAGE) and reacted in a Western blot assay with serum samples from EBA patients. lgG antibodies in these sera bound to a major 290 kD protein and a minor 145 kD protein, the EBA antigen(s) . Moreover, the antibodies in the patients' sera did not recognize any of the known matrix molecules in identical Western blot assays with purified components. In addition, the EBA antigen migrates differently on SDS-PAGE from other known matrix molecules, including laminin, fibronectin , collagens type I, IV, and V, the bullous pemphigoid antigen, and elastin. In this study, we have used a human skin BMZ extract as an immunogen to develop a mouse monoclonal antibody directed against the EBA antigen. This monoclonal antibody, H3a, should be valuable in further isolation and characterization of the EBA antigen. Manuscript received June 25, 1984; accept.ed for publication October 15, 1984. This work was supported by grants from the National Institutes of Health (5 ROl AM10546, 5 R01 AM 30475, and 1 R01 AM 33625). Reprint requests to: Amy S. Paller, M.D., Depart ment of Dermatol-ogy, Rush-Presbyterian-St. Luke's Medical Center, 1753 W. Congress Parkway, Chicago, Illinois 60612. Abbreviations: BMZ: basement membrane zone EBA: epidermolysis bullosa acquisita FITC: fluorescein isothiocyanate PBS: phosphate-buffered saline SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electro-phoresis 215 MATERIALS AND METHODS Preparation of Dermal BMZ Extract Whole human skin sections were separated at the level of the lamina Iucida by incubation in 1M sodium chloride solution at 4"C for 4 days. The dermal extract was subsequently prepared by extraction for 1 h with 8 M urea and 0.3 M beta-mercaptoethanol in 0.5 M Tris-hydro-chloride, pH 8.5, according to the method of Scaletta et al (5] . Preparation of the Hybrid Cell Line and the Hybridoma Antibodies The H3a hybridoma was produced by convent ional techniques with the modifications described by Goldsmith and Briggaman [6]. BALE/ c mice (Charles River, Wilmington, Massachusetts) were immunized wit h an i.p. injection of 2.5 mg of 1-h BMZ extract in 0.25 ml phosphate-buffered saline (PBS) homogenized with an equal volume of complete Freund's adjuvant. Four weeks later a booster of 1 mg BMZ extract in 0.5 ml PBS (wit hout adjuvant) was given i.p. , and a final booster of 1 mg BMZ extract in 0.5 ml PBS was injected 3 days before harvesting of the mouse spleen. Nonsecreting P3/NS1 mouse myeloma cells were fused with splenic lymphocytes, and grown in HMT medium over STO cell feeder layers (HGPRT-negative mouse fibroblast lines). Culture supernatants were screened for anti -B MZ antibodies by indirect im-munofluorescence using neonatal human foreskin as substrate, and cultures of interest were cloned by limiting dilution. The supernatants of monoclonal cell cultures were collected and concentrated by ultrafiltration using an XM50 Amicon membrane molecular weight cut-off 50,000 (Amicon Corp., Danvers, Massachu~ setts). The antibody was then purified by DEAE Affi-gel Blue cllfo-matography (Bio-Rad Laboratories, Richmond, California) using a Tris-HCI .02 M, pH 7.2 buffer [7]. and 70 mM NaCI to elute the IgG. Ant ibody protein concentration was determined by absorbance spec-trophotometry at OD280, and final ant ibody t iter was ascertained by indirect immunofluorescence of serial dilut ions. Assays Immunofluorescence: Frozen tissues were cut in 8-J.Lm sections and air-dried on glass slides. Sections were overlaid with undiluted hybri-doma culture media, or EBA sera diluted 1:20, incubated in a moist chamber at room temperature for 30 min, and t hen washed with PBS. The t issue was subsequently treated with fluoresceinated goat anti-mouse IgG or antihuman IgG (1:20 dilutions, Cappel Laboratories Cochranville, Pennsylvania) fo r 30 min and washed with PBS. Th~ slides were mounted in 90% glycerol-PBS and examined under a Leitz fluorescent microscope. Immunoelectron microscopy: Frozen specimens were cut into 10-J.Lm sections and air-dried. The t issue was incubated with undiluted H3a supernatant or control media for 30 min in a moist chamber at room temperature and washed with PBS. The tissue was subsequently treated with fluorescein isothiocyanate (FITC)-goat anti mouse IgG diluted 1:20 in PBS, FITC-rabbit antigoat IgG diluted 1:1 in PBS with 50% normal rabbit serum , goat anti-horseradish peroxidase diluted 1:1 in PBS wi th 50% normal rabbit serum (Cappel Laboratories, Cochranville, Penn-sylvania) and finally, horseradish peroxidase 1 mg per 20 ml PBS (Sigma, St. Louis, Missouri), all steps separated by washing in PBS twice. Tissues were subsequently fixed in 2.5% glutaraldehyde, stained with Hanker-Yates reagent (Polysciences, Warrington, Pennsylvania) in 0.1 M Tris buffer, pH 7.5, with 1% H20 2 and postfixed in 1% osmium tetroxide in 0.1 M phosphate buffer. The specimen then was serially dehydrated in 50-100% ethanol, embedded in Epon, sectioned with a diamond knife, and examined in a JEM 100B electron microscope. SDS-PAGE and Western immunoblot analysis: The extracted BMZ proteins were separated by SDS-PAGE as described by Laemmli [8] under reducing conditions using 5% separating gels and 3% stacking 216 PALLER ET AL gels. T he separated proteins were electrophoretically transferred from t he acrylamide gels to nitrocellulose paper (Western blot) overnight at 60 rnA using a Hoefer t ransblot apparatus (Hoefer Scientific Instru-ments, San Francisco, California) [9]. The nitrocellulose sheet was cut into strips of one la ne each. A high-molecular-weight lane and a BMZ extract lane were stained with 0.1% am ido black. The remaining nitrocellulose strips were saturated with 3% bovine serum a lbumin in Tris-buffered saline for 1 h, then washed and incubated for 4 h with undiluted H3a supernatant, medium, or EBA serum, diluted 1:200. The strips were washed 8 times, and subsequently incubated for 3- 4 h with 1251-labeled affin ity-purified rabbit antimouse IgG F(ab') 2 (for H3a supernatant and media) or [125l ]staphylococcal protein A (for EBA serum) prepared by the method of Hunter and G ree nwood [10]. Strips were washed twice, then overnight, exposed to Kodak X-Omat film for up to 72 h at -70"C, and developed. The rabbit antiserum to mouse lgG F(ab')2 fragments (Cappel Lab-oratories, West Chester, Pennsylvania) was purified by precipitation at 45 % ammonium sulfate and chromatography on DEAE-cellulose [11]. The lgG fraction was af!in ity purified on mouse IgG Sepharose which was produced by 45% ammonium sulfate precipitation of mouse lgG, purification on DEAE-cellulose [11], and coupling to Sepharose 48 by the method of Parikh et al [12]. The affinity-purified rabbi t antimouse JgG fraction was subsequently eluted with 1.0 M acetic acid in to tubes contain ing 1.0 M unbuffered Tris base, and dialyzed. This affinity-purified rabbit antimouse lgG F(ab'h was labeled with [1251] Nal (Amersham, Arlington Heights, Illinois) to a specific activity of 4.9 X 104 cpm per ng [10] . The ability of the labe led antibody to detect mouse antibody was tested with a monoclonal antibody to epithelial cells, and was confirmed by fluorescence studies conducted in parallel. Characterization of the Monoclonal Antibody Antibody isotypin.g: Standard Ouchterlony double-diffusion tech-niques were employed for typing the monoclonal antibody using im-munoglobulin class-specific rabbit antimouse antisera against the fol-lowing determinants: G1, G2a, G2b, G3, M, A, kappa light chain, and lambda light chain (Bionetics, Charleston, South Carolina). Complement fixation: Complement fixation was assessed by incuba-tion of neonatal human foreskin for 30 min with H3a, then with human C3 in a moist chamber at 37"C for 45 min. After washing with PBS, we added goat antihuman C3 (1:10 dilution, Cappel Laboratories, Cochranville, Pennsylvania) for 30 min and washed with PBS. Slides were mounted in 90% glycerol-PBS. Staphylococcal protein A binding: Tissue treated with H3a was overlaid with undiluted nuorescein-conjugated staphylococcal protein A for 30 min, washed, and examined. In addition, [125l]staphylococcal protein A labeling of H3a-treated nitrocellulose papers with BMZ extracts was compared with [125l]rabbit anti mouse labe ling of Western immunoblots. RESULTS Immunofluorescence and lmmunoelectron Microscopic Studies Indirect immunofluorescence staining of normal human skin with H3a showed a linear band of fluorescence at the dermal-epidermal junction without staining of vascular BMZ (Fig 1). Sections treated with HMT medium rather than H3a were FIG 1. Linear deposition of H3a by immunof1uorescence at the BMZ of human neonatal foreskin (X 870). Vol. 84, No.3 FIG 2. Immunoelectron micrograph prepared with H3a antibody shows the localization of reaction product (arrow) in and below the lamina densa (LD). Lamina Iucida (LL) is free of reaction products. Hemidesmosomes (H) were stained equally on both control and anti-body (H3a)-treated specimens. AF = anchoring fibrils. Uranyl acetate and lead citrate. Calibration bar= 1 J.Lffi. FIG 3. Immunoelectron micrograph with H3a antibody. An area of dermal-epidermal junction is seen in which a basal keratinocyte (K) and melanocyte (M) are adjacent, with dermis (D) beneath. Reaction products (arrow) are present beneath the keratinocyte but absent under the melanocyte. Uranyl acetate and lead citrate. Calibration bar = 1 J.Lffi . devoid of fluorescence. Sections treated with serum samples from EBA patients showed a linear pattern of fluorescence identical to that seen with H3a, except that the background nonspecific fluorescence was much greater when polyclonal EBA sera were used. Ultrastructural immunoperoxidase staining of normal hu-man skin incubated with H3a revealed a heavy continuous band of electron-dense reaction product localized to the lamina densa and immediate sublamina densa regions without prefer-ential aggregation at sites of anchoring fibrils or hemidesmo-somes (Fig 2). This pattern was also seen with immunoelectron microscopy of tissue sections treated with sera from patients with EBA. The band of electron-dense deposition followed the contour of the basal keratinocytes but was diminished or absent beneath the plasma membrane of melanocytes (Fig 3). March 1985 H3 290 _..,. -I I I 145 FIG 4. Identical binding patterns of H3a and polyclonal EBA serum antibodies to 145 and 290 kD proteins of junctional extract by Western immunoblot analysis. The left two lanes were treated with H3a antibody (H3a), and the third and fourth lanes with sera from 2 different patients with EBA (EBA ). SDS-PAGE and Western. Jmmunoblot Analysis Lanes of the BMZ extract transferred to nitrocellulose paper and stained with amido black revealed more than 100 protein bands. When identical unstained lanes were incubated with H3a antibody, the antibody bound to 2 bands: a major band of 290 kD and a minor band of 145 kD (Fig 4). These protein bands were also bound by antibodies in serum samples from 7 patients with EBA, but not with serum samples from normal individuals or patients with other blistering diseases. H3a did not bind in the Western immunoblots to known matrix com-ponents, including elastin, laminin, fibronectin and collagens type I, IV, and V. Characterization of the H3a Monoclonal Antibody By isotype analysis, the H3a was an lgG" kappa antibody. The monoclonal antibody showed no binding to complement or staphylococcal protein A. The protein concentration of pur-ified antibody ranged from 5.7-20 mg/ ml with a limiting dilu-tion titer of 1:400 to 1:3200. DISCUSSION In this study, we have described a new monoclonal antibody, H3a, which is specifically directed against the EBA antigen. EPIDERMOLYSIS BULLOSA ACQUJSITA ANTIGEN 217 This monoclonal antibody binds to an antigen localized to the lamina densa and sublamina densa region, a pattern which matches that of polyclonal antibodies from patients with EBA . Even more convincing are the data from the Western immu-noblot experiments in which both H3a and sera from EBA patients bound to 290 kD and 145 kD proteins in extracts of human skin basement membrane. The monoclonal nature of H3a is supported by finding only one immunoglobulin subclass (IgG ~> kappa) produced by this hybridoma. When compared with immunofluorescent staining using the polyclonal EBA serum antibodies, the H3a monoclonal anti-body stains the dermal -epidermal junction of normal human skin with minimal nonspecific background fluorescence . H3a promises to be useful in assessing the distribution of the EBA antigen in various human and animal tissues, as well as in studying its appearance in gestational development and relative concentration in different human tissue sites. Finally, the mon-oclonal antibody in its unlimited supply should be valuable in isolating and subsequently further characterizing the EBA an-tigen itself. REFERENCES 1. Nieboer C, Boorsma DM, Woerdeman MJ, Kalsbeek GL: Epider-molysis bullosa acquis ita: immunofluorescence, e lectron micro-scopic and immunoelectron microscopic studies in four patients. Br J Dermatol 102:383-392, 1980 2. Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI: Epi -dermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76:288-292, 1981 3. Wilson BD, Birnkrant AF, Beutner EH, Maize JC: Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. J Am Acad Dermatol 3:280-291, 1980 4. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR: Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita. N Eng! J Med 310:1007-1013, 1984 5. Scaletta LJ, Occhino J C, MacCallum DK, Lillie JH: Isolation and immunologic identilication of basement membra ne zone anti-gens from human skin. Lab Invest 39:1- 9, 1978 6. Goldsmith LA, Briggaman RA: Monoclonal antibodies to normal and abnormal epithelial antigens, Normal and Abnormal Epi -dermal Differention. Edited by M Seiji, IA Bernstein. Tokyo, Univ of Tokyo Press, 1983, pp 3-25 7. Bruck C, Portelle D, Glineur C, Bollen A: One-step purification of mouse monoclonal antibodies from asc itic fluid by DEAE Affi-Gel Blue chromatography. J Immunol Methods 53:313-319, 1982 8. Laemmli UK: Cleavage of structural prote ins during assembly of the head of bacteriophage T,. Nature 227:680-685, 1970 9. Towbin H, Staehelin T , Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: pro-cedure and some applications. Proc Nat Acad Sci USA 76:4350-4354, 1979 10. Hunter WM, Greenwood FC: Preparation of iodine-131- labelled human growth hormone of high specific activity. Nature 194:495-496, 1962 11. Fahey JL, Terry EW: Ion exchange chromatography and gel filtra-tion, Handbook of Experimental Immunology, vol 1, 3d ed. Edited by DM Weir. Oxford, Blackwell Scientific, 1978, pp 8.1 -8.16 12. Parikh I, March S, Cuatrecasas P: Topics in the methodology of substitution reactions wi th aga rose. Methods Enzymol 34:77-102, 1974 

A Mouse Monoclonal Antibody Against a Newly Discovered Basement Membrane Component, the Epidermolysis Bullosa Acquisita Antigen

https://cdr.lib.unc.edu/downloads/4j03d840b

A Mouse Monoclonal Antibody Against a Newly Discovered Basement Membrane Component, the Epidermolysis Bullosa Acquisita Antigen

Abstract

Similar works

Full text

Available Versions

Carolina Digital Repository